Fina Biosolutions Announces European Patent for Conjugate Vaccine Development
![Fina Biosolutions LLC Logo](https://r1f5c3.p3cdn1.secureserver.net/wp-content/uploads/2018/09/FinaBio-Logo-News.jpg?time=1721822922)
Proprietary method of producing CRM197 will be used to develop affordable vaccines for children and adults in developing nations Rockville, MD., November 4, 2020– Fina Biosolutions LLC (“FinaBio”) is very…